18/07/2022 (Agence Europe) – On Monday 18 July, the European Commission announced that it had purchased in an anticipatory manner 54,530 doses of the monkeypox vaccine Imvanex, sold by the firm Bavarian Nordic. This is an amendment to the original contract (see EUROPE B12971A4) which brings the total number of doses purchased by the European Commission’s Health and Digital Executive Agency (HaDEA) on behalf of the European Health Emergency Preparedness and Response Authority (HERA) to...